Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002514267 | SCV003523224 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2O; Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 | 2022-09-06 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 56599). This variant is also known as 541delT, Phe149 frameshift 167Stop. This premature translational stop signal has been observed in individual(s) with muscle–eye–brain disease (PMID: 12588800). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Phe149Leufs*19) in the POMGNT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in POMGNT1 are known to be pathogenic (PMID: 19299310, 20816175, 21447391, 26908613, 27391550). |
Juha Muilu Group; Institute for Molecular Medicine Finland |
RCV000050012 | SCV000082421 | probable-pathogenic | Muscle eye brain disease | no assertion criteria provided | not provided | Converted during submission to Likely pathogenic. |